The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1) (NCT05862857) | Clinical Trial Compass
CompletedNot Applicable
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)
Kenya, Uganda9,375 participantsStarted 2023-07-13
Plain-language summary
This study will test innovative interventions to increase uptake and use of biomedical HIV prevention options by engaging women and men at drinking venues in rural Kenya and Uganda in care, while gaining insights into the facilitators, barriers, and cost-effectiveness of these approaches.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participant Inclusion Criteria:
* adult (≥18 years)
* patron or worker at a drinking venue within the study community
Exclusion Criteria:
* none
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study focused on HIV prevention outreach at alcohol venues in East Africa — if I spend time in similar social settings, is this kind of community-based prevention approach something that might be relevant to my situation?
2The trial measured whether people actually followed through with biomedical HIV prevention — like PrEP or other methods — within 4 weeks of being reached. If I'm considering PrEP or similar prevention, how quickly would I need to act for it to be effective, and what barriers might get in the way for me specifically?
3Since this study is already completed, are there published results showing whether the outreach approach worked, and what would those findings mean for the prevention options available to me now?
4This trial was conducted in East Africa and focused on alcohol venues as an outreach setting — how well do you think those findings would translate to my own community and circumstances, or are there local programs I should look into instead?
5Given that this was a prevention-focused study rather than a treatment trial, and I've just been diagnosed, should we be focusing more on treatment options right now, and separately, how does this kind of research affect the support or resources available to people in my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Biomedical HIV Prevention Uptake at 4 Weeks
Timeframe: Measured 4 weeks after clinic screening visit